- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06743815
The Percent of AKI Occurred in Patient with Comorbidities Undergoing Colonoscopy
December 17, 2024 updated by: Mahmoud Abd Elbasset Abd Elmoula Ahmed, Assiut University
Predictors of AKI in Patient Undergoing Colonoscopy
observation the percent AKI in patient with comorbidities undergoing colonoscopy
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
recording the data of the patient if there are any comorbidities like DM or HTN and observation of the kidney functions before and after the colonoscopy to record the percent of the AKI in patient undergoing colonoscopy
Study Type
Observational
Enrollment (Estimated)
113
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mahmoud abdelbaset Abd El moula, resident doctor
- Phone Number: +201151392662
- Email: m.abdelbasset15@gmail.com
Study Contact Backup
- Name: AlShaima sayed Hassan, lecturer
- Phone Number: +201096883911
- Email: Shaimaa_nephro@aun.edu.eg
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
adult patient >18 years old with eGFR.30ml/min
Description
Inclusion Criteria:
- Adult patient aged >18 years old Patient with eGFR>30ml/min
Exclusion Criteria:
- patient with eGFR <30ml/min patient with serum electrolytes abnormalities patient with heart diseases (uncontrolled heart failure, unstable angina, myocardial infarction, coronary intervention within the previous 3 months) patients with ascites
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
group
patients subjective for colonoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of acute kidney injury
Time Frame: 30 day
|
the incidence of acute kidney injury in patients undergoing colonoscopy
|
30 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 30, 2025
Primary Completion (Estimated)
January 1, 2026
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
December 17, 2024
First Submitted That Met QC Criteria
December 17, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 17, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- aki and colonoscopy (Other Identifier: Assiut University)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.